Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Dec;111(6):1400-10.
doi: 10.1213/ANE.0b013e3181f7181c. Epub 2010 Sep 22.

The cytoprotective effects of dantrolene: a ryanodine receptor antagonist

Affiliations
Review

The cytoprotective effects of dantrolene: a ryanodine receptor antagonist

Saadet Inan et al. Anesth Analg. 2010 Dec.

Abstract

Calcium, as a second messenger, has an important role in a variety of cellular functions. However, disruption of intracellular calcium homeostasis leads to cytotoxicity and cell death. Excessive calcium release from intracellular stores, via the calcium channel ryanodine receptor, contributes to cell damage. Dysfunction of calcium homeostasis is established in tissue culture and animal models of ischemia, hypoxia, seizure, trauma, anesthesia, and neurodegenerative diseases. Dantrolene, the primary drug to treat malignant hyperthermia, is a ryanodine receptor antagonist. Dantrolene inhibits abnormal calcium release from the sarco-endoplasmic reticulum, which is the primary intracellular calcium store. Dantrolene has been investigated widely for its possible cytoprotective effects against cell damage in different tissue culture or animal models of diseases involving cytotoxicity induced by disruption of intracellular calcium homeostasis in pathogenesis. In this review, we summarize the role of the disruption of intracellular calcium homeostasis on cell death, the pharmacologic and pharmacokinetic features of dantrolene, and the cytoprotective effects and potential application of dantrolene for the inhibition of cell damage in a wide variety of models of stress and disease.

PubMed Disclaimer

Conflict of interest statement

Disclosure: The authors report no conflicts of interest.

Figures

Figure 1.
Figure 1.
Chemical structures of dantrolene (A) and azumolene (B).
Figure 2.
Figure 2.
The models of cytotoxicity induced by Ca2+ dysregulation in excitotoxicity (i.e., sepsis, seizure, trauma), neurodegenerative diseases, and general anesthesia. Under normal conditions, [Ca2+] in the extracellular space is 10,000 times higher than the cytosolic Ca2+ concentration ([Ca2+]c). Upon electrical or receptor-mediated stimulation, [Ca2+]c is increased by extracellular Ca2+ influx via specific ion channels on the plasma membrane including voltage-dependent calcium channels (VDCCs) and ligand-gated calcium channels or by Ca2+ release from intracellular stores. The main intracellular Ca2+ store in neurons is the endoplasmic reticulum (ER) and Ca2+ is released into the cytosol via activation of ryanodine receptors (RYRs) and inositol-1,4,5-triphosphate receptors (InsP3Rs). Basal [Ca2+]c is maintained through calcium binding and calcium buffering proteins or uptake into internal stores by the energy-dependent sarco-ER calcium pump (SERCA) at the ER membrane or by the mitochondrial uniporter. Disturbance in Ca2+ homeostasis leads to cytotoxicity. Abnormal increase in intracellular [Ca2+] is the result of either increased extracellular Ca2+ influx via Ca2+ channels or increased release from the ER by either calcium-induced calcium release (CICR) or overactivation of RYRs and InsP3Rs. During excitotoxic conditions (i.e., ischemia, sepsis, seizure, trauma), glutamate release is increased. Glutamate stimulates N-methyl-d-aspartate (NMDA), kainate (KA), α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), and metabotropic glutamate mGluR1/5 receptors. Amyloid-β peptide (Aβ) synthesis is increased in Alzheimer disease (AD) and forms oligomers. Both Aβ oligomers and α-synuclein, which aggregates in Parkinson disease (PD), can form Ca2+ permeable pores in the plasma membrane and facilitates the increase of [Ca2+]c. Aβ oligomers also activate NMDA and KA receptors as well as VDCCs and cause Ca2+ influx. Activation of mGluR1/5 increases inositol-1,4,5-triphosphate (InsP3), which activates the InsP3R and causes Ca2+ release from the ER. Evidence suggests that the InsP3R is sensitized to InsP3 during Huntington disease (HD), spinothalamic cerebellar ataxies (SCAs), and general anesthesia by isoflurane. Dantrolene is cytoprotective via inhibiting RYRs and preventing excessive Ca2+ release from the ER, especially during CICR. Reduction in ER Ca2+ stores results in the misfolding of proteins, which stimulates the unfolding protein response as a cellular stress response. Influx of Ca2+ into mitochondria causes the formation of oxygen radicals and energy failure as a consequence of decreased adenosine triphosphate (ATP) production. When cytosolic Ca2+ binds to calmodulin (CaM), nitric oxide synthase (NOS) is activated and nitric oxide (NO) is produced. Oxygen radicals react with NO and forms peroxynitrite, which damages DNA and proteins. DNA cleavage activates the DNA-repair enzyme poly (ADP-ribose) polymerase (PARP), which requires energy for its activation. PARP-induced energy depletion worsens cellular stress. Increased [Ca2+] in mitochondria increases mitochondrial permeability via the mitochondrial permeability transition pore (MtPTP), which causes mitochondrial swelling, outer mitochondrial membrane rupture, and release of cytochrome c (CytC). CytC activates pro-apoptotic factors (caspases) by reacting with Ca2+-activated calpain and induces apoptosis via intrinsic pathways.

Similar articles

Cited by

References

    1. Tsutsumi Y, Yamamoto K, Matsuura S, Hata S, Sakai M, Shirakura K. The treatment of neuroleptic malignant syndrome using dantrolene sodium. Psychiatry Clin Neurosci 1998;52: 433–8 - PubMed
    1. Dykes MH. Evaluation of a muscle relaxant: dantrolene sodium (Dantrium). JAMA 1975;231:862–4 - PubMed
    1. Krause T, Gerbershagen MU, Fiege M, Weisshorn R, Wappler F. Dantrolene: a review of its pharmacology, therapeutic use and new developments. Anaesthesia 2004;59:364–73 - PubMed
    1. Hadad E, Cohen-Sivan Y, Heled Y, Epstein Y. Clinical review: treatment of heat stroke—should dantrolene be considered? Crit Care 2005;9:86–91 - PMC - PubMed
    1. Hall AP, Henry JA. Acute toxic effects of ‘Ecstasy’ (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth 2006;96:678–85 - PubMed

Publication types

MeSH terms